{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:58:08Z","timestamp":1787237888566,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6S","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Implant-based reconstruction represents the most common method of breast reconstruction today. Many surgeons approach implant-based breast reconstruction in 2 stages, with the first stage being placement of a tissue expander at the time of mastectomy. Neoadjuvant chemotherapy can have systemic effects that may place patients at risk for TE\/implant loss, infection, wound, and other complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective review of all cases of TE breast reconstruction at a single institution between 2017 and 2024 was performed. A total of 210 patients, representing 319 total breasts that underwent reconstruction, met the inclusion criteria. Sixty-five patients underwent neoadjuvant chemotherapy and 145 did not. Patients were separated into neoadjuvant chemotherapy (NACT) and nonneoadjuvant chemotherapy (non-NACT) cohorts. Primary outcomes of TE loss, wound, infection, and seroma were analyzed. Regression analysis was performed, matching patients for known risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The rate of all-cause TE loss in patients who underwent NACT was 18%, and 11% for patients who did not. The rate of pathologic TE loss was significantly higher at 14% in patients who underwent NACT and 7% in patients who did not undergo NACT (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.032). On regression analysis, neoadjuvant chemotherapy increased the rate of all-cause and pathologic TE loss by 17% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05). There were no statistically significant differences in wound, seroma, and infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In this study, neoadjuvant chemotherapy is an independent risk factor for TE loss after immediate tissue expander-based breast reconstruction. Further analysis of adjuncts, implant factors, and specific chemotherapeutic agents is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/sap.0000000000004707","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T15:01:29Z","timestamp":1773241289000},"page":"S430-S435","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The Effect of Neoadjuvant Chemotherapy on Implant Loss in Immediate Tissue Expander-Based Breast Reconstruction"],"prefix":"10.1097","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7301-0424","authenticated-orcid":false,"given":"Robert G.","family":"DeVito","sequence":"first","affiliation":[{"name":"Department of Plastic Surgery, Maxillofacial and Oral Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Wen","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Virginia, Charlottesville, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hibo M.","family":"Wehelie","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Maxillofacial and Oral Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Mendoza","family":"Isaula","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Virginia, Charlottesville, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Kumar","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Virginia, Charlottesville, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Hollenbeck","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Maxillofacial and Oral Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Stranix","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Maxillofacial and Oral Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris A.","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Maxillofacial and Oral Health"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"R1-20260601","doi-asserted-by":"crossref","first-page":"437e","DOI":"10.1097\/PRS.0000000000008229","article-title":"Understanding the evidence and improving outcomes with implant-based prepectoral breast reconstruction","volume":"148","author":"Campbell","year":"2021","journal-title":"Plast Reconstr Surg"},{"key":"R2-20260601","doi-asserted-by":"crossref","first-page":"898e","DOI":"10.1097\/PRS.0000000000006721","article-title":"Prepectoral direct-to-implant breast reconstruction: safety outcome endpoints and delineation of risk factors","volume":"145","author":"Nealon","year":"2020","journal-title":"Plast Reconstr Surg"},{"key":"R3-20260601","doi-asserted-by":"crossref","first-page":"421e","DOI":"10.1097\/PRS.0000000000006510","article-title":"Recent advances in implant-based breast reconstruction","volume":"145","author":"Colwell","year":"2020","journal-title":"Plast Reconstr Surg"},{"key":"R4-20260601","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/PRS.0b013e31824a2acb","article-title":"The use of acellular dermal matrix in immediate two-stage tissue expander breast reconstruction","volume":"129","author":"Weichman","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"R5-20260601","first-page":"CD005002","article-title":"Preoperative chemotherapy for women with operable breast cancer","volume":"2007","author":"Mieog","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20260601","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/jamasurg.2014.1076","article-title":"Neoadjuvant chemotherapy and short-term morbidity in patients undergoing mastectomy with and without breast reconstruction","volume":"149","author":"Abt","year":"2014","journal-title":"JAMA Surg"},{"key":"R7-20260601","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1245\/s10434-016-5162-y","article-title":"Impact of neoadjuvant and adjuvant chemotherapy on immediate tissue expander breast reconstruction","volume":"23","author":"Dolen","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R8-20260601","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bjps.2023.09.048","article-title":"The impact of neoadjuvant chemotherapy on surgical outcomes following autologous and implant-based immediate breast reconstruction: a systematic review and meta-analysis","volume":"87","author":"Sabitovic","year":"2023","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R9-20260601","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jamasurg.2021.2239","article-title":"Association of clinical complications of chemotherapy and patient-reported outcomes after immediate breast reconstruction","volume":"156","author":"Hart","year":"2021","journal-title":"JAMA Surg"},{"key":"R10-20260601","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.clbc.2023.12.004","article-title":"Effects of neoadjuvant chemotherapy on autologous and implant-based breast reconstruction: a systematic review and meta-analysis of the literature","volume":"24","author":"Nag","year":"2024","journal-title":"Clin Breast Cancer"},{"key":"R11-20260601","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa2414859","article-title":"Omitting regional nodal irradiation after response to neoadjuvant chemotherapy","volume":"392","author":"Mamounas","year":"2025","journal-title":"N Engl J Med"},{"key":"R12-20260601","doi-asserted-by":"crossref","first-page":"845","DOI":"10.6004\/jnccn.2018.7022","article-title":"Outcomes following neoadjuvant chemotherapy for breast cancer in women aged 40 years and younger: impact of pathologic nodal response","volume":"16","author":"Kozak","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"R13-20260601","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1097\/GOX.0000000000000598","article-title":"Locally advanced breast cancer: autologous versus implant-based reconstruction","volume":"4","author":"Tanos","year":"2016","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"R14-20260601","doi-asserted-by":"crossref","first-page":"ojac036","DOI":"10.1093\/asjof\/ojac036","article-title":"Tissue expander-based breast reconstruction at a major safety-net hospital: managing the outsized risk of infection","volume":"4","author":"Urquia","year":"2022","journal-title":"Aesthet Surg J Open Forum"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000004707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:00:13Z","timestamp":1780322413000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000004707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":14,"journal-issue":{"issue":"6S","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0000000000004707","relation":{},"ISSN":["0148-7043","1536-3708"],"issn-type":[{"value":"0148-7043","type":"print"},{"value":"1536-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"2025-08-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}